Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06IEX
|
|||
Former ID |
DIB006931
|
|||
Drug Name |
Cardiotrophin-1
|
|||
Synonyms |
Cardiotrophin-1 (acute liver failure/obesity/interferon stimulator)
Click to Show/Hide
|
|||
Indication | Acute liver failure [ICD-11: DB91] | Phase 1 | [1], [2] | |
Company |
Digna Biotech SL
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Cardiotrophin-1 (CTF1) | Target Info | Stimulator | [3] |
KEGG Pathway | Cytokine-cytokine receptor interaction | |||
Jak-STAT signaling pathway | ||||
WikiPathways | MicroRNAs in cardiomyocyte hypertrophy | |||
Physiological and Pathological Hypertrophy of the Heart |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4906). | |||
REF 2 | ClinicalTrials.gov (NCT01334697) Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Cardiotrophin-1 in Healthy Volunteers. U.S. National Institutes of Health. | |||
REF 3 | Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.